ADR Biomedical HoldingsADR Biomedical Holdings Inc.3750東証スタンダード情報・通信業FY ending Mar 2026, consolidated, J-GAAP
ADR Biomedical Holdings brought in ¥51M in revenue.
It lost about ¥1777 for every ¥100 of sales at the operating level.
Revenue changed -58.3% from the prior year.
FY ending Mar 2025 → FY ending Mar 2026
FY ending Mar 2025 → FY ending Mar 2026
For every ¥100 ADR Biomedical Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第22期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
訂正有価証券報告書-第21期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第20期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
訂正有価証券報告書-第19期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第18期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第17期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 42
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.